The store will not work correctly when cookies are disabled.
4-ethyl-6-(4-(4-methoxyphenyl)-5-methyl-1H-pyrazol-3-yl)benzene-1,3-diol
ID: ALA4218027
Chembl Id: CHEMBL4218027
PubChem CID: 145970747
Max Phase: Preclinical
Molecular Formula: C19H20N2O3
Molecular Weight: 324.38
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CCc1cc(-c2n[nH]c(C)c2-c2ccc(OC)cc2)c(O)cc1O
Standard InChI: InChI=1S/C19H20N2O3/c1-4-12-9-15(17(23)10-16(12)22)19-18(11(2)20-21-19)13-5-7-14(24-3)8-6-13/h5-10,22-23H,4H2,1-3H3,(H,20,21)
Standard InChI Key: ILPQRCXIAXLJCC-UHFFFAOYSA-N
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 324.38 | Molecular Weight (Monoisotopic): 324.1474 | AlogP: 4.03 | #Rotatable Bonds: 4 |
Polar Surface Area: 78.37 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.76 | CX Basic pKa: 2.56 | CX LogP: 4.35 | CX LogD: 4.33 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.68 | Np Likeness Score: -0.27 |
References
1. Vo CD, Shebert HL, Zikovich S, Dryer RA, Huang TP, Moran LJ, Cho J, Wassarman DR, Falahee BE, Young PD, Gu GH, Heinl JF, Hammond JW, Jackvony TN, Frederick TE, Blair JA.. (2017) Repurposing Hsp90 inhibitors as antibiotics targeting histidine kinases., 27 (23): [PMID:29110989] [10.1016/j.bmcl.2017.10.036] |